Preview

Пульмонология

Расширенный поиск

Европейская сеть по глобальной аллергии и астме (GA2LEN) изучает "эпидемию" аллергии и астмы

https://doi.org/10.18093/0869-0189-2009-4-119-126

Полный текст:

Список литературы

1. Bousquet J., Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Global Alliance Against Chronic Respiratory Diseases. Wld Health Organization. ISBN 978 92 4 156346 8. 2007: 148 pages.

2. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 2001; 108 (suppl. 5): S147-S334.

3. Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (suppl. 86): 8-160.

4. Walker S., Khan(Wasti S., Fletcher M. et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: casecontrol study. J. Allergy Clin. Immunol. 2007 Aug.; 120 (2): 381-387.

5. Shaaban R., Zureik M., Soussan D. et al. Rhinitis and onset of asthma: a longitudinal populationbased study. Lancet 2008; 372 (9643): 1049-1057.

6. Sullivan S.D., Turk F. An evaluation of the costeffectiveness of omalizumab for the treatment of severe allergic asthma. Allergy 2008; 63 (6): 670-684.

7. Bousquet J., Neukirch F., Bousquet P.J. et al. Severity and impairment of allergic rhinitis in patients consulting in pri" mary care. J. Allergy Clin. Immunol. 2006; 117 (1): 158-162.

8. Bousquet J., Demarteau N., Mullol J. Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 2005; 60 (6): 788-794.

9. Zuberbier T., Lötvall J. Allergies have a socioeconomic impact. European Academy of Allergology and Clinical Immunology, annual meeting. Barcelona June 2008. Allergy 2008; suppl. 84.

10. -2013 Action plan for the global strategy for the prevention and control of non communicable diseases. Prevent and control cardiovascular diseases, cancers, chronic respiratory diseases, diabetes. www.hoint/nmh/Actionplan-PC-NCD-2008pdf. 2008.

11. Bousquet J., Bieber T., Fokkens W. et al. Important questions in allergy: novel research areas. Allergy 2008; 63 (2): 143-147.

12. Bousquet J., Fokkens W., Burney P. et al. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy 2008; 63 (7): 842-853.

13. Demoly P., Pichler W., Pirmohamed M., Romano A. Important questions in allergy: 1-drug allergy / hypersensitivity. Allergy 2008; 63 (5): 616-619.

14. Bachert C. et al. Important research questions in allergy and related diseases. 3-chronic rhinonsinusitis. Allergy 2009: in press.

15. Van Cauwenberge P., Watelet J.B., Van Zele T. Spreading excellence in allergy and asthma: the GA2LEN (Global Allergy and Asthma European Network) project. Allergy 2005; 60 (7): 858-864.

16. Warner J.O. Global Allergy and Asthma European Network (GA2LEN) - a focus for paediatric allergy research. Pediatr. Allergy Immunol. 2006; 17 (3): 163.

17. Frew A.J. GA2LEN - The Global Allergy and Asthma European Network. Clin. Exp. Allergy 2005; 35 (2): 122-125.

18. Heinzerling L., Frew A.J., Bindslev-Jensen C. et al. Standard skin prick testing and sensitization to inhalant allergens across Europe - a survey from the GALEN network. Allergy 2005; 60 (10): 1287-1300.

19. Nizankowska-Mogilnicka E., Bochenek G., Mastalerz L. et al. Aspirin provocation tests for diagnosis of aspirin sensitivity. EAACI / GA2LEN guideline. Allergy 2007; 62 (10): 1111-1118.

20. Turjanmaa K., Darsow U., Niggemann B. et al. EAACI / GA2LEN position paper: present status of the atopy patchtest. Allergy 2006; 61 (12): 1377-1384.

21. Werfel T., Ballmer-Weber B., Eigenmann P.A. et al. Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN. Allergy 2007; 62 (7): 723-728.

22. Carlsen K.H., Anderson S.D., Bjermer L. et al. Treatment of exerciseinduced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN. Allergy 2008; 63 (5): 492-505.

23. Carlsen K.H., Anderson S.D., Bjermer L. et al. Exerciseinduced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 2008; 63 (4): 387-403.

24. Bonini S., Rasi G., Brusasco V. et al. Nonspecific provocation of target organs in allergic diseases: EAACIGA(2)LEN consensus report. Allergy 2007; 62 (6): 683-694.

25. Burney P., Potts J., Makowska J. et al. A case-control study of the relation between plasma selenium and asthma in European populations: a GA2LEN project. Allergy 2008; 63 (7): 865-871.

26. Shaheen S., Potts J., Gnatiuc L. et al. The relation between paracetamol use and asthma: a GA2LEN European case-control study. Eur. Respir. J. 2008; 32 (5): 1231-1236.

27. Keil T., Kulig M., Simpson A. et al. European birth cohort studies on asthma and atopic diseases: I. Comparison of study designs - a GALEN initiative. Allergy 2006; 61 (2): 221-228.

28. Keil T., Kulig M., Simpson A. et al. European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures - a GALEN initiative. Allergy 2006; 61 (9): 1104-1111.

29. Eller E., Roll S., Chen C.M., Herbarth O. et al. Metaanalysis of determinants for pet ownership in 12 European birth cohorts on asthma and allergies: a GA2LEN initiative. Allergy 2008 Nov.; 63 (11): 1491-1498.

30. Almqvist C., Worm M., Leynaert B. Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 2008; 63 (1): 47-57.

31. Tricon S., Willers S., Smit H. et al. Nutrition and allergic diseases. Clin. Exp. Rev. 2006; 6: 117-188.

32. Papadopoulos N.G., Xepapadaki P., Mallia P. et al. Mechanisms of virus-induced asthma exacerbations: state-of-the art. A GA2LEN and InterAirways document. Allergy 2007; 62 (5): 457-470.

33. Meiler F., Zumkehr J., Klunker S. et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 2008; 205 (12): 2887-2898.

34. Brunekreef B. Environmental epidemiology and risk assessment. Toxicol Lett. 2008 Aug. 15; 180 (2): 118-122.

35. Brunekreef B. Health effects of air pollution observed in cohort studies in Europe. J. Expo Sci. Environ. Epidemiol. 2007; 17 (suppl. 2): S61-S65.

36. Madsen C., Lodrup-Carlsen K., Hoek G. et al. Modeling the intraurban variability of outdoor traffic pollution in Oslo, Norway-A GA2LEN study. Atmosph. Environ. 2007; 41: 7500-7511.

37. Aguilera I., Sunyer J., Fernandez-Patier R. et al. Estimation of outdoor NO(x), NO(2), and BTEX exposure in a cohort of pregnant women using land use regression modeling. Environ. Sci. Technol. 2008; 42 (3): 815-821.

38. Kogevinas M., Zock J.P., Jarvis D. et al. Exposure to substances in the workplace and new-onset asthma: an interna tional prospective population-based study (ECRHS-II). Lancet 2007; 370 (9584): 336-341.

39. Radon K., Gerhardinger U., Schulze A. et al. Occupation and adult onset of rhinitis in the general population. Occup. Environ. Med. 2008; 65 (1): 38-43.

40. Medina-Ramon M., Zock J.P., Kogevinas M. et al. Short-term respiratory effects of cleaning exposures in female domestic cleaners. Eur. Respir. J. 2006; 27 (6): 1196-1203.

41. Radon K., Huemmer S., Dressel H. et al. Do respiratory symptoms predict job choices in teenagers? Eur. Respir. J. 2006; 27 (4): 774-778.

42. Riu E., Dressel H., Windstetter D. et al. First months of employment and new onset of rhinitis in adolescents. Eur. Respir. J. 2007; 30 (3): 549-555.

43. Bousquet J., Anto J.M., Bachert C. et al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GALEN project. Allergy 2006; 61 (6): 671-680.

44. Bousquet P.J., Chatzi L., Jarvis D., Burney P. Assessing skin prick tests reliability in ECRHS-I. Allergy 2008; 63 (3): 341-346.

45. Bousquet P.J., Hooper R., Kogevinas M. et al. Number of allergens to be tested to assess allergenic sensitization in epidemiologic studies: results of the European Community Respiratory Health Survey I. Clin. Exp. Allergy 2007; 37 (5): 780-787.

46. Bousquet P.J., Leynaert B., Neukirch F. et al. Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey I. Allergy 2008; 63 (10): 1301-1309.

47. Watelet J.B., Van Zele T., Gjomarkaj M. et al. Tissue remodelling in upper airways: where is the link with lower airway remodelling? Allergy 2006; 61 (11): 1249-1258.

48. Gagliardo R., La(Grutta S., Chanez P. et al. Noninvasive markers of airway inflammation and remodeling in childhood asthma. Pediatr. Allergy Immunol. 2009; in press.

49. Lang A., Carlsen K.H., Haaland G. et al. Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy 2008; 63 (8): 1054-1060.

50. Carlsen K.H., Kowalski M.L. Asthma, allergy, the athlete and the Olympics. Allergy 2008; 63 (4): 383-386.

51. Baiardini I., Braido F., Brandi S. et al. The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. Allergy 2008; 63 (8): 1015-1030.

52. Baiardini I., Braido F., Tarantini F. et al. ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy 2008; 63 (6): 660-669.

53. Bousquet J., Zuberbier T., Mullol J. ACCEPT-1 Study Group icwGL. Improvement in disease-specific quality of life and reduced symptom burden measured with a visual analogue scale in subjects with intermittent allergic rhinitsi treated with desloratadine. Allergy 2008; 62 (suppl. 64).

54. Bousquet J., del-Carpio J., Group A.-S. Improvement in disease-specific quality of life and reduced symptom burden measured with a visual analogue scale in subjects with persistent allergic rhinitis treated with desloratadine. American College of Allergy, Asthma and Immunology, Seattle, November 2008.

55. Kabesch M. Gene by environment interactions and the development of asthma and allergy. Toxicol Lett. 2006; 162 (1): 43-48.

56. Kauffmann F., Cambon-Thomsen A. Tracing biological collections: between books and clinical trials. J. A. M. A. 2008; 299 (19): 2316-2318.

57. Passalacqua G., Bousquet P.J., Carlsen K.H. et al. ARIA update: I-systematic review of complementary and alternative medicine for rhinitis and asthma. J. Allergy Clin. Immunol. 2006; 117 (5): 1054-1062.

58. Bonini S., Bonini M., Bousquet J. et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy 2006; 61 (6): 681-692.

59. Cruz A.A., Popov T., Pawankar R. et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007; 62 (suppl. 84): 1-41.

60. Bousquet J., Bindslev-Jensen C., Canonica G.W. et al. The ARIA / EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Allergy 2004; 59 (suppl. 77): 4-16.

61. Bousquet J., van Cauwenberge P., Ait Khaled N. et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN). Allergy 2006; 61 (9): 1086-1096.

62. Custovic A., Wijk R.G. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy 2005; 60 (9): 1112-1115.

63. Passalacqua G., Durham S.R. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J. Allergy Clin. Immunol. 2007; 119 (4): 881-891.

64. van Weel C. General practitioners' central role in management of asthma and allergic rhinitis. Allergy 2008; 63 (8): 1005-1007.

65. Ryan D., van Weel C., Bousquet J. et al. Primary care: the cornerstone of diagnosis of allergic rhinitis. Allergy 2008; 63 (8): 981-989.

66. Bousquet J., Reid J., van Weel C. Allergic rhinitis management pocket reference 2008. Allergy 2008; 63 (8): 990-996.

67. Zuberbier T., Worm M. Allergies and the skin, an interdisciplinary approach in GA(2)LEN and EAACI activities. Allergy 2006; 61 (12): 1373-1376.

68. Zuberbier T., Bindslev(Jensen C., Canonica W. et al. EAACI / GA2LEN / EDF guideline: management of urticaria. Allergy 2006; 61 (3): 321-331.

69. Zuberbier T., Bindslev(Jensen C., Canonica W. et al. EAACI / GA2LEN / EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006; 61 (3): 316-320.

70. Brozek J.L., Baena(Cagnani C.E., Bonini S. et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy 2008; 63 (1): 38-46.


Для цитирования:


Буске Д., Буске П., Брунекриф Б., Каноника Д., Карлсен К., Гемаркай М., Ховарт П., Лензен Д., Лотвалл Д., Радон К., Ринг Д., Салапатас М., Шунеман Х., Щеклик А., Тодо-Бом А., Валовирта Е., Вон Мутиус Е., Бачерт С., Овернье Н., Бурней П., Зубербир Т., Ван Ковенберг П., Акдис С., Бинслевйенсен С., Бонини С., Фоккенс В., Кауфманн Ф., Ковальски М., Лодрап-Карлсен К., Муллол Д., Низанковска-Могилника Е., Пападопулос Н., Тоскала Е., Викман М., Анто Д., Зок Д. Европейская сеть по глобальной аллергии и астме (GA2LEN) изучает "эпидемию" аллергии и астмы . Пульмонология. 2009;(4):119-126. https://doi.org/10.18093/0869-0189-2009-4-119-126

Просмотров: 28


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)